|
1.
Albrink
MJ. Chorionic gonadotropin and obesity?. Am J Clin Nutr 1969
Jun;22(6):681-5
|
| 2.
ASCHEIM S; ZONDEK B. Die Shwangerschafts Diagnose aus dem Harn
durch nachweis der Hypophysovorderlappenhormone. Klin. Wochschr.
7:1401-1411. 1928
|
| 3.
Asher
WL. Harper HW. Effect of human chorionic gonadotrophin on weight
loss. hunger. and feeling of well-being. Am J Clin Nutr 1973
Feb;26(2):211-8
|
| 4.
Astrup
A.. VLCD compliance and lean body mass. Int J Obes 1989;13
Suppl 2:27-31
|
| 5.
Atkinson
JH. et al.. Plasma measures of beta-endorphin/beta-lipotropin-like
immunoreactivity in chronic pain syndrome and psychiatric subjects.
Psychiatry Res. 1983 Aug;9(4):319-27
|
| 6.
Bagshawe
KD. et al.. Pregnancy beta1 glycoprotein and chorionic
gonadotrophin in the serum of patients with trophoblastic and non-trophoblastic
tumors. Eur J Cancer. 1978 Dec;14(12):1331-5
|
| 7.
Balducci R. et al.. Effect of hCG or hCG+ treatments in young
thalassemic patients with hypogonadotropic hypogonadism. J
Endocrinol Invest. 1990 Jan;13(1):1-7
|
| 8.
Ballin
JC. White PL. Fallacy and hazard. Human chorionic gonadotropin-500-calorie
diet and weight reduction. JAMA 1974 Nov 4;230(5):693-4
|
| 9.
Bastow
MD. Anthropometrics revisited. Proc Nutr Soc 1982
Sep;41(3):381-8
|
| 10.
Berry JN. Use of skinfold thickness for estimation of body fat.
Indian J Med Res 1974 Feb;62(2):233-9
|
| 11.
Birken
S. et al.. Isolation and amino acid sequence of COOH-terminal
fragments from the beta subunit of human choriogonadotropin. J
Biol Chem. 1977 Aug 10;252(15):5386-92
|
| 12.
Birken
S.. Chemistry of human choriogonadotropin. Ann Endocrinol
(Paris). 1984;45(4-5):297-305
|
| 13.
Birmingham
CL. et al.. Human chorionic gonadotropin is of no value in the
management of obesity. Can Med Assoc J. 1983 May
15;128(10):1156-7
|
| 14.
Bonandrini
L. et al.. Chorionic gonadotropin (HCG) in the therapy of chronic
peripheral obliterating arteriopathy (CPOA) of the lower
extremities caused by arteriosclerosis. Minerva Chir. 1970 Mar
15;25(5):368-83
|
| 15.
Borkan GA et al.. Comparison of ultrasound and skinfold
measurements in assessment of subcutaneous and total fatness.
Am J Phys Anthropol 1982 Jul;58(3):307-13
|
| 16.
Borkan
GA, Hults DE, Gerzof SG, Burrows BA, Robbins AH.Relationships
between computed tomography tissue areas, thicknesses and total
body composition. Ann Hum Biol. 1983 Nov-Dec;10(6):537-45.
|
| 17.
Bosch
B. et al.. Human chorionic gonadotrophin and weight loss. A double-blind.
placebo-controlled trial. S Afr Med J 1990 Feb 17;77(4):185-9
|
| 18.
Bousfield
GR. et al.. Structural features of mammalian gonadotropins. Mol
Cell Endocrinol. 1996 Dec 20;125(1-2):3-19
|
| 19.
Bozzola
M. et al.. Effect of human chorionic gonadotropin on growth
velocity and biological growth parameters in adolescents with
thalassemia major. Eur J Pediatr. 1989 Jan;148(4):300-3
|
| 20.
Bradley
P. Human chorionic gonadotrophin [letter]. Med J Aust Sep
25;2(13):510-1 1976
|
| 21.
Brambilla
F. et al.. beta-Endorphin and beta-lipotropin plasma levels in
chronic schizophrenia. primary affective disorders and secondary
affective disorders. Psychoneuroendocrinology. 1981 Dec;6(4):321-30
|
| 22.
Bujanow
W. Hormones in the treatment of psychoses. Br Med J Nov
4;4(835):298 1972
|
23.
Bujanow
W.Letter: Is oxytocin an anti-schizophrenic hormone?
Can Psychiatr Assoc J. 1974 Jun;19(3):323. No abstract available. |
| 24.
Cairella
M.. Drug therapy of obesity. Clin Ter. 1978 Mar
31;84(6):571-92
|
| 25.
Canfield
RE. et al.. Studies of human chorionic gonadotropin. Recent
Prog Horm Res. 1971;27:121-64
|
| 26.
Cole
LA.. Immunoassay of human chorionic gonadotropin. Its free subunit
and metabolites. Clin Chem. 1997 Dec;43(12):2233-43
|
| 27.
Emrich
HM. Endorphins in psychiatry. Psychiatr Dev 1984 Summer;2(2):97-114
|
| 28.
Ferrari
C.. Use of a testosterone-gonadotropin combination in the
treatment of pathological syndromes in adult males. Minerva
Med. 1972 Jun 2;63(42):2399-408
|
| 29.
Fiddes
JC. et al.. Structure. expression. and evolution of the genes for
the human glycoprotein hormones. Recent Prog Horm Res.
1984;40:43-78
|
| 30.
Fiddes
JC. et al.. The gene encoding the common alpha subunit of the four
human glycoprotein hormones. J Mol Appl Genet. 1981;1(1):3-18
|
| 31.
Fleigelman R. Metabolic effects of human chorionic gonadotropin (HCG)
in rats. Proc Soc Exp Biol Med 1970 Nov;135(2):317-9
|
| 32.
Gailani
S. et al.. Human chorionic gonadotrophins (hCG) in non-trophoblastic
neoplasms. Assessment of abnormalities of hCG and CEA in
bronchogenic and digestive neoplasms. Cancer. 1976
Oct;38(4):1684-6
|
| 33.
Gallo
RC. Bryant J. Antitumor effects of hCG in KS. Nat Biotechnol
Mar;16(3):218 1998
|
| 34.
Giudice
LC. et al.. Glycoprotein hormones: some aspects of studies of
secondary and tertiary structure. Monograph. 1979 May 23
|
| 35.
Greenway
FL. et al.. Human chorionic gonadotropin (HCG) in the treatment of
obesity: a critical assessment of the Simeons method. West J
Med 1977 Dec;127(6):461-3
|
| 36.
Grzonkowski
S. Analysis of the results of the measurements of adipose tissue
in the human body based on the study of skinfold thickness.
Przegl Epidemiol 1989;43(3):272-82
|
| 37.
Gusman HA. Chorionic gonadotropin in obesity. Further clinical
observations. Am J Clin Nutr 1969 Jun;22(6):686-95
|
| 38.
Hashimoto
TK. Chorionic gonadotropin preparation as an analgesic. Arch
Intern Med 1981 Feb;141(2):269
|
| 39.
Hayes
PA. Sub-cutaneous fat thickness measured by magnetic resonance
imaging, ultrasound , and calipers. Med Sci Sports Exerc 1988
Jun;20(3):303-9
|
| 40.
Weiss LW, Clark FC.Three protocols for
measuring subcutaneous fat thickness on the upper extremities.http://Eur
J Appl Physiol. 1987;56(2):217-21.
|
| 41.
Heitmann
BL et al. Evaluation of body fat estimated from body mass index,
skinfolds and impedance. A comparative study. Eur J Clin Nutr
1990 Nov;44(11):831-7
|
| 42.
Hermans
P. Clumeck N. Picard O. et. Al.. AIDS-related Kaposi's sarcoma
patients with visceral manifestations. Response to human chorionic
gonadotropin preparations. J Hum Virol Jan-Feb;1(2):82-9. 1998
|
| 43.
LaPorte
DJ. Predicting attrition and adherence to a very low calorie diet:
a prospective investigation of the eating inventory. Int J
Obes 1990 Mar;14(3):197-206
|
| 44.
LaPorte
DJ. Treatment response in obese binge eaters: preliminary results
using a very low calorie diet (VLCD) and behavior therapy.
Addict Behav 1992;17(3):247-57
|
| 45.
Leshem Y. et al.. Gonadotropin promotion of adventitious root
production on cuttings of Begonia semperflorens and Vitis vinifera.
Plant Physiol. 1968 Mar;43(3):313-7
|
| 46.
Lustbader
JW. et al.. Structural and molecular studies of human chorionic
gonadotropin and its receptor. Recent Prog Horm Res.
1998;53:395-424
|
| 47.
Malkin A. The presence of glycosilated, biologically active
chorionic gonadotropin in human liver. Clin Biochem 1985 Apr;18(2):75-7
|
| 48.
Maruo
T. et al.. Production of Choriogonadotropin-like factor by a
microorganism. Proc Natl Acad Sci U S A. 1979 Dec;76(12):6622-6
|
| 49.
McGarvey
ME. Tulpule A. et. Al.. Emerging treatments for epidemic (AIDS-related)
Kaposi's sarcoma. Curr Opin Oncol Sep;10(5):413-21 1998
|
| 50.
Miller
R. et al.. A clinical study of the use of human chorionic
gonadotrophin in weight reduction. J Fam Pract. 1977
Mar;4(3):445-8
|
| 51.
Morgan
FJ. et al.. Chemistry of human chorionic gonadotropin.
Monograph. 1976 May 25
|
| 52.
Mueller
WH. Relative reliability of circumferences and skinfolds as
measures of body fat distribution. Am J Phys Anthropol 1987
Apr;72(4):437-9
|
| 53.
Niebroj
TK. et al.. Effect of chorionic gonadotropins administration on
water metabolism in glaucomatous women. Endokrynol Pol. 1971
May-Jun;22(3):251-5
|
| 54.
Orphanidou
C. Accuracy of subcutaneous fat measurement: comparison of
skinfold calipers. ultrasound, and computed tomography. J Am
Diet Assoc 1994 Aug;94(8):855-8
|
| 55.
Orphanidou
CI, McCargar LJ, Birmingham CL, Belzberg AS.Changes
in body composition and fat distribution after short-term weight
gain in patients with anorexia nervosa.Am J
Clin Nutr. 1997 Apr
;
65 (4) :1034-41.
|
| 56.
Perniola
R. et al.. Human chorionic gonadotrophin therapy in hypogonadal
thalassaemic patients with osteopenia: increase in bone mineral
density. J Pediatr Endocrinol Metab. 1998;11 Suppl 3:995-6
|
| 57.
Pickar D et al.. Clinical studies of the endogenous opioid system.
Biol Psychiatry 1982 Nov;17(11):1243-76
|
| 58.
Pierce
JG.. Eli Lilly lecture. The subunits of pituitary
thyrotropin--their
relationship to other glycoproteic hormones. Endocrinology.
1971 Dec;89(6):1331-44
|
| 59.
Rabe
T. et al.. Risk-benefit analysis of a hCG-500 kcal reducing diet
(cura romana) in females. Geburtshilfe Frauenheilkd. 1987
May;47(5):297-307
|
| 60.
Reiss
M.. Stunted growth and the mechanism of its stimulation in
mentally disturbed adolescents. Int J Neuropsychiatry. 1965
Aug;1(4):313-7
|
| 61.
Rivlin
RS.. Therapy of obesity with hormones. N Engl J Med. 1975 Jan
2;292(1):26-9
|
| 62.
Ross
GT.. Clinical relevance of research on the structure of human
chorionic gonadotropin. Am J Obstet Gynecol. 1977 Dec
1;129(7):795-808
|
| 63.Sanders
S, Norman AP.Chorionic gonadotrophin in male growth-retarded
adolescent asthmatic patients.Practitioner. 1973
May;210(259):690-2.
|
| 64.
Sarma
JM. Houghten RA. Enzyme linked immunosorbent assay (ELISA) for
beta-endorphin and its antibodies. Life Sci 1983;33 Suppl
1:129-32
|
| 65.
Sarria
A et al.. Skinfold thickness measurements are better predictors of
body fat percentage than body mass index in male Spanish children
and adolescents. Eur J Clin Nutr 1998 Aug;52(8):573-6
|
| 66.
Scaffidi
A. Data on the pathogenesis and therapy of bronchial asthma in
patients with secondary hypogonadism. Minerva Med Dec
1;65(86):4473-6 1974
|
| 67.
Segal SJ (ed.). Chorionic Gonadotropin. Plenum Press: NY. 1980
|
| 68.
Shetty
KR. et al.. Human chorionic gonadotropin (HCG) treatment of
obesity. Arch Intern Med. 1977 Feb;137(2):151-5
|
| 69.
Shomer-Ilan
A. et al.. Further evidence for the presence of an endogenous
gonadotrophin-like plant factor: "phytotrophin" .Isolation
and mechanism of action of the active principle. Aust J Biol
Sci. 1973 Feb;26(1):105-12
|
| 70.
Simeons ATW. The action of chorionic gonadotropin in the obese.
Lancet II:1954: 946-947
|
| 71.
Simeons ATW.. Pounds and Inches: A new approach to obesity.
Private Printing (1976)
|
| 72.
Stein
MR. et al.. Ineffectiveness of human chorionic gonadotropin in
weight reduction: a double-blind study. Am J Clin Nutr. 1976
Sep;29(9):940-8
|
| 73.
Stern
JS.. Weight control programs. Curr Concepts Nutr.
1977;5:137-55
|
| 74.
Suginami
H. et al.. Immunohistochemical localization of a human chorionic
gonadotropin-like substance in the human pituitary gland. J
Clin Endocrinol Metab. 1982 Dec;55(6):1161-6
|
| 75.
Tagliabue
A et al.. Application of bioelectric impedance measurement in the
evaluation of body fat. Recenti Prog Med 1989 Feb;80(2):59-62
|
| 76.
Talbot
LA et al.. Assessing body composition: the skinfold method.
AAOHN J 1995 Dec;43(12):605-13
|
| 77.
Tavio
M. Nasti G. Simonelli C. et. Al.. Human chorionic gonadotropin in
the treatment of HIV-related Kaposi's sarcoma. Eur J Cancer
Sep;34(10):1634-7 1998
|
| 78.
Torgerson
JS et al.. VLCD plus dietary and behavioral support versus support
alone in the treatment of severe obesity. A randomised two-year
clinical trial. Int J Obes Relat Metab Disord 1997
Nov;21(11):987-94
|
| 79.
Vaitukaitis JL.. Glycoprotein hormones and their
subunits--immunological
and biological characterization. Monograph. 1979 May 23
|
| 80.
Veilleux H. et al.. Gonadic and extragonadic effects in humans of
3.500 I.U. of HCG (human chorionic gonadotropin) in fractional
doses. Vie Med Can Fr. 1972 Sep;1(9):862-71
|
| 80b.Vogt
T, Belluscio D.Controversies
in plastic surgery: suction-assisted lipectomy (SAL) and the hCG
(human chorionic gonadotropin) protocol for obesity treatment.
Aesthetic Plast Surg. 1987;11(3):131-56. Review.
|
| 81.
Wattanapenpaiboon
N. et al.. Agreement of skinfold measurement and bioelectrical
impedance analysis (BIA) methods with dual energy X-ray
absorptiometry (DEXA) in estimating total body fat in Anglo-Celtic
Australians. Int J Obes Relat Metab Disord. 1998
Sep;22(9):854-60
|
| 82.
Weits
T. et al.. Comparison of ultrasound and skinfold caliper
measurement of subcutaneous fat tissue. Int J Obes
1986;10(3):161-8
|
| 83.
Yanagihara
Y. Carbohydrate and lipid metabolism in pregnant albino rats
during hunger after loading with gonad-stimulating hormones.
Nippon Sanka Fujinka Gakkai Zasshi 1966 Nov;18(11):1293-301
|
| 84.
Yanagihara Y. Carbohydrate and fatty acid metabolism in pregnant
albino rats simultaneously loaded with fat emulsion and sex
stimulating hormones during starvation. Nippon Sanka Fujinka
Gakkai Zasshi 1967 Jan;19(1):8-14
|
| 85.
Yanagihara
Y. Carbohydrate and lipid metabolism in pregnant albino rats
during starvation after loading with gonad-stimulating hormones.
Nippon Sanka Fujinka Gakkai Zasshi 1966 Dec;18(12):1379-84
|
| 86.
Yoshimoto Y. et al.. Human chorionic gonadotropin--like material:
presence in normal human tissues. Am J Obstet Gynecol. 1979
Aug 1;134(7):729-33
|
| 87.
Yoshimoto
Y. et al.. Human chorionic gonadotropin-like substance in
nonendocrine tissues of normal subjects. Science. 1977 Aug
5;197(4303):575-7
|
| 88.
Young
RL. et al.. Chorionic gonadotropin in weight control. A double-blind
crossover study. JAMA. 1976 Nov 29;236(22):2495-7
|
| 89.
Zakut
H. et al.. hCG as tumor marker in non-trophoblastic neoplasms.
Harefuah. 1985 Jan 15;108(2):82-5
|
| 90. Zondek B. Sulman F. The mechanism of action and metabolism of
gonadotrophic hormones in the organism. Vit Horm 1945 3:297-336
|
Para
consultas y comentarios